Skip to content

Effect of Dexmedetomidine nebulisation for headache after anaesthesia given by back injection

Effectiveness of nebulised Dexmedetomidine for treatment of Post-Dural Puncture Headache in Parturients undergoing elective Cesarean Section under Spinal Anaesthesia - A Randomised Controlled Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060850
Enrollment
60
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics Health Condition 2: O894- Spinal and epidural anesthesia-induced headache during the puerperium

Interventions

Intervention1: DEXMEDETOMIDINE: We will give nebulisation with dexmedetomidine 1micro grams/kg diluted in 4ml 0.9% saline twice daily starting from the PDPH diagnosis and for 3 days. Control Interven

Sponsors

SRM MEDICAL COLLEGE HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Post-partum females diagnosed with PDPH after caesarean section under spinal anesthesia Age between 20- 40 years old ASA I and ASA II

Exclusion criteria

Exclusion criteria: Patient refusal. Hypertensive disorders of the pregnancy Uncontrolled DM History of chronic headache, migraine, convulsions, and cerebrovascular accident.

Design outcomes

Primary

MeasureTime frame
Comparing the headache severity scoreTimepoint: Comparing the headache severity score at 24, 48, 72 hours after the onset of PDPH during post operative period.

Secondary

MeasureTime frame
-Need for epidural blood patch - Patient satisfaction score - Comparison of hemodynamical parameters - Analgesics consumptionTimepoint: Comparing at 24, 48, 72 hours after the onset of PDPH during post operative period.

Countries

India

Contacts

Public ContactDR C R SARAVANAN

SRM MEDICAL COLLEGE AND HOSPITAL

drcrsaravanan@gmail.com9884001153

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026